References
- Akbarzadeh, A.; Rezaei-Sadabady, R.; Davaran, S.; Joo, S. W.; Zarghami, N.; Hanifehpour, Y.; Samiei, M.; Kouhi, M.; Nejati-Koshki, K., et al. Liposome: Classification, Preparation, and Applications. Nanoscale Res. Lett. 2013, 8(1), 102. DOI: https://doi.org/10.1186/1556-276X-8-102.
- Colletier, J. P.; Chaize, B.; Winterhalter, M.; Fournier, D. Protein Encapsulation in Liposomes: Efficiency Depends on Interactions between Protein and Phospholipid Bilayer. BMC Biotechnol. 2002, 2, 9. DOI: https://doi.org/10.1186/1472-6750-2-9.
- Daraee, H.; Etemadi, A.; Kouhi, M.; Alimirzalu, S.; Akbarzadeh, A. A pplication of Liposomes in Medicine and Drug Delivery. Artif. Cells Nanomed. Biotechnol. 2016, 44(1), 381–391. DOI: https://doi.org/10.3109/21691401.2014.953633.
- Varna, M.; Juenet, M.; Bayles, R.; Mazighi, M.; Chauvierre, C.; Letourneur, D. Nanomedicine as a Strategy to Fight Thrombotic Diseases. Future Sci. OA. 2015, 1(4), FSO46. DOI: https://doi.org/10.4155/fso.15.46.
- Greineder, C. F.; Howard, M. D.; Carnemolla, R.; Cines, D. B.; Muzykantov, V. R. Advanced Drug Delivery Systems for Antithrombotic Agents. Blood. 2013, 122(9), 1565–1575. DOI: https://doi.org/10.1182/blood-2013-03-453498.
- Koudelka, S.; Mikulik, R.; Masek, J.; Raška, M.; Turánek Knotigová, P.; Miller, A. D.; Turánek, J., et al. Liposomal Nanocarriers for Plasminogen Activators. J. Controlled Release. 2016, 227, 45–57. DOI: https://doi.org/10.1016/j.jconrel.2016.02.019.
- Masumeh, Z.; Mehdi, F.; Morteza, E.; Mahmoudi, J.; Barar, J.; Rafi, M.; Omidi, Y., et al. Recent Advances in Targeted Delivery of Tissue Plasminogen Activator for Enhanced Thrombolysis in Ischaemic Stroke. J. Drug Targeting. 2018, 26(2), 95–109.
- Stability and Characterization of Protein and Peptide Drugs. In Pharmaceutical Biotechnology, 5. Eds., Pearlman, R., and Wang, Y. J. 91-129, Plenum Press: New York, USA; 1993.
- Absar, S.; Nahar, K.; Kwon, Y. M.; Ahsan, F. Thrombus-targeted Nanocarrier Attenuates Bleeding Complications Associated with Conventional Thrombolytic Therapy. Pharm. Res. 2013, 30(6), 1663–1676. DOI: https://doi.org/10.1007/s11095-013-1011-x.
- Adivitiya, Y. P.; Khasa, Y. P. The Evolution of Recombinant Thrombolytics: Current Status and Future Directions. Bioengineered. 2017, 8(4), 331–358. DOI: https://doi.org/10.1080/21655979.2016.1229718.
- Kim, J. Y.; Kim, J. K.; Park, J. S.; Byun, Y.; Kim, C. K. The Use of PEGylated Liposomes to Prolong Circulation Lifetimes of Tissue Plasminogen Activator. Biomaterials. 2009, 30(29), 5751–5756. DOI: https://doi.org/10.1016/j.biomaterials.2009.07.021.
- Paternostre, M.;. Liposomes: Preparation and Membrane Protein Reconstitution. In Manual on Membrane Lipids. 202-247, Berlin Heidelberg: Springer-Verlag, 1996. DOI: https://doi.org/10.1007/978-3-642-79837-5
- Dubatouka, K. I.; Agabekov, V. E.; Lutsik, I. L.; Yatsevich, V. N.; Adzerikho, I. E. Effect of Liposomal Streptokinase on the D-dimers Formation. Doklady Natl. Acad. Sci. Belarus. 2016, 60(6), 54–58.
- Bradford, M. M. A Rapid and Sensitive Method for the Estimation of Microgram Quantities of Protein Utilizing the Principle of Protein-dye Binding. Anal. Biochem. 1976, 72, 248–254. DOI: https://doi.org/10.1016/0003-2697(76)90527-3.
- Compton, S. J.; Jones, G. G. Mechanism of Dye Response and Interference in the Bradford Protein Assay. Anal. Biochem. 1985, 151, 369–374. DOI: https://doi.org/10.1016/0003-2697(85)90190-3.
- Saxena, V.; Gacchina Johnson, C.; Negussie, A. H.; Sharma, K. V.; Dreher, M. R.; Wood, B. J. Temperature-sensitive Liposome-mediated Delivery of Thrombolytic Agents. Int. J. Hyperthermia. 2015, 31(1), 67–73. DOI: https://doi.org/10.3109/02656736.2014.991428.
- Franzé, S.; Selmin, F.; Samaritani, E.; Minghetti, P.; Cilurzo, F. Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging. Pharmaceutics. 2018, 10(3), 139. DOI: https://doi.org/10.3390/pharmaceutics10030139.
- Vaidya, B.; Nayak, M. K.; Dash, D.; Agrawal, G. P.; Vyas, S. P. Development and Characterization of Site Specific Target Sensitive Liposomes for the Delivery of Thrombolytic Agents. Int. J. Pharm. 2011, 403(1–2), 254–261. DOI: https://doi.org/10.1016/j.ijpharm.2010.10.028.
- Shaw, G. J.; Meunier, J. M.; Huang, S. L.; Lindsell, C. J.; McPherson, D. D.; Holland, C. K. Ultrasound-enhanced Thrombolysis with tPA-loaded Echogenic Liposomes. Thromb. Res. 2009, 124(3), 306–310. DOI: https://doi.org/10.1016/j.thromres.2009.01.008.
- Lin, J.; Wu, H.; Wang, Y.; Lin, J.; Chen, Q.; Zhu, X. Preparation and Ocular Pharmacokinetics of Hyaluronan Acid-modified Mucoadhesive Liposomes. Drug. Deliv. 2016, 23(4), 1144–1151. DOI: https://doi.org/10.3109/10717544.2014.991952.
- Chaize, B.; Colletier, J. P.; Winterhalter, M.; Fournier, D. Encapsulation of Enzymes in Liposomes: High Encapsulation Efficiency and Control of Substrate Permeability. Artif. Cells Blood Subst. Immobil. Biotechnol. 2004, 32(1), 67–75. DOI: https://doi.org/10.1081/BIO-120028669.